http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2620496-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c227755a1075fc682e2a336aebdbbf9e |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-245 |
| filingDate | 2016-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15633637092fb6a3a6b3129fbfa0f4d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_641a73e82fa4771249d2d3efab691f9d |
| publicationDate | 2017-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2620496-C1 |
| titleOfInvention | Method for intraoperative prophylactic treatment of ischemic damage to pancreas and liver in case of combined shock-producing injury |
| abstract | FIELD: medicine. n SUBSTANCE: method of cannulation of the splenic artery and splenic vein is used after the performed splenectomy to perform regional intra-arterial and intravenous perfusion therapy. Solutions are injected at a volumetric rate that allows the fastest possible normalisation of the systemic blood pressure, which should not be less than 70 mm Hg. At that, up to 60% of the infusion volume is injected through the arterial access, and intraarterial infusion includes perfluorane - 400.0 ml, 0.25% novocaine solution 100.0, 0.9% NaCl solution 400.0 and Contrykal 300 thous. units, Ringer's solution 500.0 and mexidol 300 mg, 0.9% NaCl solution 400.0 and 5-fluorouracil 500 mg; perfluorane 400.0 ml, reopolyglucin 400 ml, gelafusin 500 ml are injected simultaneously intravenously. Infusion is performed in a thermostated version at 37ºC at the background of local hypothermia of the pancreatobiliary zone. In a situation requiring application of the technique of stepwise "damage control" interventions, catheters for intra-arterial and intravenous infusion are withdrawn to the anterior abdominal wall, continuing the regional anti-shock therapy as part of the anti-shock therapy complex. A laparostome is applied. On day 2-3, programmed relaparotomy is performed. The final amount of intervention is performed on the abdominal organs, vessels catheterization is eliminated, arterial and venous accesses are ligated. n EFFECT: method allows to reduce the frequency of acute traumatic pancreatitis and acute hepatic insufficiency in case of combined shock-producing injury, to increase the survival rate of patients of young and middle working age with severe shock-associated injuries, to exclude severe stage complications of traumatic disease, to reduce lethality in this category of victims. n 2 cl, 2 ex, 3 dwg |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2765846-C1 |
| priorityDate | 2016-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 129.